clopidogrel and Debility

clopidogrel has been researched along with Debility in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bessette, LG; Cervone, A; Cheng, S; Glynn, RJ; Kim, DH; Ko, D; Lee, SB; Lin, KJ; Pande, A1
Bell, JS; Farinola, N; Hauta-Aho, M; Huupponen, R; Johns, S; Korhonen, MJ; Shakib, S; Teperi, S1
Alexander, KP; Armstrong, PW; Clemmensen, P; Fox, KA; Goodman, SG; Hochman, JS; Kaul, P; Ohman, EM; Prabhakaran, D; Roe, MT; Savu, A; White, HD1

Trials

1 trial(s) available for clopidogrel and Debility

ArticleYear
Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.
    The Canadian journal of cardiology, 2019, Volume: 35, Issue:4

    Topics: Acute Coronary Syndrome; Aged; Aging; Clopidogrel; Comorbidity; Exercise; Female; Frailty; Hand Strength; Humans; Male; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prevalence; Prognosis; Self Report; Sex Factors; Walking Speed

2019

Other Studies

2 other study(ies) available for clopidogrel and Debility

ArticleYear
Utilization of P2Y
    The American journal of cardiology, 2023, 11-15, Volume: 207

    Topics: Aged; Clopidogrel; Female; Frailty; Humans; Male; Medicare; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; United States

2023
Frailty and Co-Prescribing of Potentially Interacting Drugs in New Users of Warfarin.
    Drugs & aging, 2020, Volume: 37, Issue:5

    Topics: Acetaminophen; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Female; Frail Elderly; Frailty; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Warfarin

2020